iCliniq Logo
HomeHealth articlesMedical oncologytriple-negative breast cancer
Cancer

Triple-Negative Breast Cancer

Verified data
0

4 min read

Share

Outline

Triple-negative breast cancer is a rare and invasive breast cancer that lacks the main hormone receptors. Read the article to learn more about this cancer.

Written byDr. Asha. C

Medically reviewed byDr. Rajesh Gulati

Published At January 2, 2023
Reviewed AtFebruary 16, 2026

What Is Triple-Negative Breast Cancer (TNBC)?

Triple-negative breast cancer is an uncommon but aggressive and invasive breast cancer type, accounting for about 10 to 15 percent of all cases. Unlike most breast cancers,

TNBC cells lack three key receptors:

  • Estrogen receptors (ER).

  • Progesterone receptors (PR).

  • HER2 (human epidermal growth factor 2) receptors.

Because these receptors are absent, TNBC will not react to hormonal therapies or HER2-targeted treatments used for other breast cancers. However, chemotherapy remains an effective treatment option.

TNBC spreads and grows more rapidly than other cancer types. It has a higher risk of recurrence, particularly within the first three years after TNBC treatment, and is considered most serious within the first five years. After this period, the long-term outlook becomes similar to that of other breast cancer types.

What Are the Stages of Triple-Negative Breast Cancer?

Doctors use the TNM system to stage breast cancer. TNM stands for

  • T- tumor size.

  • N-lymph nodes involved.

  • M- metastasis (spread to other body organs).

The stages are as follows:

Stage 0: Cancer cells are confined to the breast ducts, with no invasion into the breast tissue.

Stage I: Cancer has spread slightly into nearby breast tissue, and the size of the tumor is small.

Stage II: The tumor size is large or more than five centimeters. Here, the cancer has not spread to nearby lymph nodes. At this stage, tumor size and lymph node involvement vary.

What Causes Triple-Negative Breast Cancer?

Mutations in multiple genes cause TNBC. However, researchers believe TNBC may be linked to changes (mutations) in the BRCA1 (breast cancer) gene. Normally, BRCA1 helps protect cells from becoming cancerous, but when it mutates, it increases the risk of developing TNBC. Other risk factors for TNBC are lifestyle choices, personal health, and ethnicity.

What Are the Symptoms of Triple-Negative Breast Cancer?

TNBC usually causes symptoms similar to other breast cancers.

Some common symptoms are:

  • Noticing a new growth or lump in the breast.

  • A whole or a part of your breast looks swollen or enlarged.

  • Skin changes, such as dimpling, thickening, or bumps.

  • Nipple pain or breast discomfort.

  • Nipple turning inward.

  • Red, dry, or flaky skin on the breast or nipple.

  • Unusual nipple discharge (other than breast milk).

  • Enlarged lymph nodes near the arm or neck.

What Are the Risk Factors for Triple-Negative Breast Cancer?

You may have a higher chance of developing TNBC if you:

  • If you are younger than 40 and were assigned female at birth.

  • Carry BRCA gene mutations, especially BRCA1, which can be inherited.

  • Are Black or Hispanic, as TNBC is more common in these groups.

Having these risk factors does not mean you will get TNBC; it only means your chances may be higher.

What Are the Skin-Related Manifestations of TNBC?

In some cases, TNBC spreads to the skin. This happens in about 20 percent of women with metastatic TNBC. Although rare, it is considered serious and requires prompt attention.

When TNBC reaches the skin, it appears in various ways, such as:

  • Red or dark skin patches.

  • Firm bumps or nodules.

  • Rashes that do not go away.

  • Ulcer-like sores.

  • Skin thickening or hardening.

How Is Triple-Negative Breast Cancer Diagnosed?

TNBC is usually diagnosed through a biopsy, which means taking a small sample of breast tissue and checking it under a microscope.

Some Steps Involved in the Diagnosis of Tnbc Are:

  1. Imaging Tests: Evaluation is performed with a mammogram, ultrasound, and MRI (magnetic resonance imaging) to assess the breast and the lump.

  2. Biopsy: If something looks suspicious, a biopsy is advised to confirm cancer. Here, a small piece of tissue is removed to determine the cancer type and the receptors present to diagnose TNBC.

  3. Staging: Once TNBC is confirmed, staging is performed by assessing tumor size, lymph node involvement, and cancer spread.

  4. Others: After cancer staging, PET (positron emission tomography) scans or CT (computed tomography) scans will be advised.

What Are the Treatment Options for Triple-Negative Breast Cancer?

TNBC is aggressive, and because the disease does not respond to hormone therapy or HER2-targeted medicines, other approaches are needed, such as

  1. Chemotherapy: It is often the first and most important treatment for TNBC. It used strong medicines to kill cancer cells. This is used before surgery to shrink the tumor and is commonly used for more advanced TNBC. Chemotherapy after surgery removes any remaining cancer cells, especially if the tumor is large or if lymph nodes were involved.

  2. Immunotherapy: This helps the body’s immune system recognize and attack cancer cells. Immunotherapy is given in conjunction with chemotherapy to shrink the tumor before performing surgery. For up to a year after surgery, sometimes with radiation, to lower the risk of the cancer returning.

  3. Surgery: It is recommended depending on the tumor size and spread. It can be of two types:

  • Surgery involves removing the whole breast, referred to as a mastectomy, and sometimes nearby lymph nodes. This is recommended if there are several tumors, cancer is in the nipple or skin, there is the presence of abnormal cells throughout the breast, there is a large tumor, or the patient has had breast cancer before.

  • Lumpectomy is the removal of just the lump and some surrounding tissue. Sometimes, nearby lymph nodes are also removed. This surgery usually takes one to two hours.

  1. Radiation Therapy: It is often given after surgery, especially after a lumpectomy. It helps kill any leftover cancer cells and reduces the risk of recurrence. A typical radiation plan is five days a week for four to six weeks, and each session lasts about 20 minutes.

  2. Targeted Therapy: It is performed using PARP (poly(ADP-ribose) polymerase) inhibitors. These are especially helpful for people with BRCA (breast cancer) gene mutations. PARP inhibitors stop cancer cells from repairing themselves, which helps kill them.

TNBC treatment side effects include hair loss, nausea, vomiting, fatigue, lymphedema, and skin changes.

Conclusion:

Triple-negative breast cancer is a less common but more serious type of breast cancer that lacks hormone and HER2 receptors. Because of its aggressive nature, it is not treated with hormonal or targeted therapies, making chemotherapy, surgery, radiation, and immunotherapy the main treatment options. Although TNBC has a higher risk of early recurrence, many patients do well with proper treatment and follow-up care. To learn more about TNBC treatment and prevention, chat with a cancer specialist who will guide you through the condition.

Key Takeaways:

  1. TNBC is aggressive and lacks estrogen, progesterone, and HER2 receptors, making it different from most other breast cancers.

  2. Hormonal and HER2-targeted treatments do not work, so chemotherapy, surgery, immunotherapy, and radiation therapy are the main treatment options.

  3. BRCA1 gene mutations increase the risk of TNBC, and genetic testing guides the treatment decisions.

Listen to related tracks in our music library

Frequently Asked Questions

Tripple-negative breast cancer is a serious and aggressive type of cancer as the cancer cells do not have estrogen, progesterone receptors, or HER2 (hormone epidermal growth factor receptor 2). Due to the absence of these receptors, the conventional treatments are ineffective, resulting in cancer cell growth and rapid spread than other breast cancers making it difficult to diagnose and treat for a positive outcome.
Triple-negative breast cancer accounts for about 10 to 15 percent of all cancers. It is common in young women below 45 years of age,  in black and Latinx, and in women with the genetic condition BRCA1 mutation.
Triple-negative breast cancer can be a terminal illness, but patients achieve remission with early detection and treatment. Regular follow-ups with the doctor and improved quality of life can tailor the patient's requirements and conditions.
Triple-negative breast cancer is diagnosed through physical examination and history, imaging tests, and biopsy. A breast examination is performed and imaging tests such as mammography, ultrasound, or MRI is advised to look for the abnormalities. If any lump is found, biopsy is performed.
Triple-negative breast cancer can be fatal as it does not have the receptors, and effective treatment is challenging. However, some patients can achieve long-term survival with early detection and appropriate treatment. The prognosis varies from person to person and depends on the cancer stage, size and location of the tumor, and overall health.
Triple-negative breast cancer (TNBC) is the most aggressive subtype with high recurrence rates, partly due to chemoresistance. A full understanding of the mechanism of TNBC is the key to overcoming chemoresistance, an effective strategy for TNBC therapy. Several potential mechanisms have been investigated, indicating that noncoding RNAs such as microRNA, long noncoding RNAs, and circular RNA are mostly involved in TNBC resistance. 
The exact mechanism is unknown and mainly known to be caused due to  BRCA1 gene mutation.
The discovery of triple-negative breast cancer is not credited to any person. However, it is known to be the subtype of breast cancer and researchers and physicians are studying the cancer type to fully understand its causes, symptoms, risk factors, and treatments.
The triple-negative breast cancer (TNBC) was termed in 2005 and referred to a subtype of breast cancer for which chemotherapy was the only available treatment option because the patient with TNBC lacked estrogen, progesterone and HER2 receptors and were ineffective with hormonal therapy.
The treatment options include,
 - Chemotherapy.
 - Surgery.
 - Radiation therapy.
 - Medications such as PARP inhibitors, immunotherapy
The stages of triple-negative breast cancer are:
 - Stage 0 - Abnormal cells confined to the milk ducts or lobes.
 - Stage 1 - Small, localized cancers that have not spread beyond a single closer lymph node.
 - Stage 2 - Moderate, regional cancers that have not spread beyond lymph nodes in the underarm area.
 - Stage 3 - Regionally advanced cancers that have spread beyond the breast but have not metastasized to distant organs.
 - Stage 4 - Metastatic malignancies that have spread to distant organs.
Chemotherapy is often used to treat triple-negative breast cancer to shrink the tumor before or after surgery and to control the recurrence of the tumor. Chemotherapy with anthracycline or taxane has better responses,  and a high risk of relapse remains if the cancer cells are not eliminated.
Yes, triple-negative breast cancer is an aggressive form of cancer with a rapid growth rate, and increased risk of metastasis and recurrence. Hence, it often needs chemotherapy as a part of treatment.
Triple-negative breast cancer is a type of cancer with negative receptors of estrogen, progesterone, and HER2. it is categorized as a subtype of basal-like breast cancer based on gene expression analysis.
The effective way to combat triple-negative breast cancer is– 
 - Chemotherapy.
 - Surgery.
 - Radiation therapy.
 - Medications such as PARP inhibitors, immunotherapy, 
 - Lifestyle modification.
 - Regular follow-ups.
No, there is no natural cure for cancer. One must talk to the doctor about the treatment options. Effective treatment includes surgery, chemotherapy,  and medications.
The risk factors include:
 - Women below age 45 years.
 - Alteration in gene expression.
 - Genetic mutations.
 - Reproductive history.
 - Lifestyle factors- less physical activity, obesity, alcohol use or smoking.
Source Article IclonSourcesSource Article Arrow
Dr. Rajesh Gulati from iCliniq
Dr. Rajesh Gulati

Family Physician

Consult this doctor

Rate this article

Tags:

triple-negative breast cancer

Related topics

Psychological Impact of Cancer

Ask your health query to a doctor online

Medical oncology

*guaranteed answer within 4 hours

Trustpilot

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.